Bank Maspion Indonesia Tbk. vs Champion Pacific Indonesia Tbk. — how do they compare? Bank Maspion Indonesia Tbk. trades at Rp476 (market cap 8.49T, 6.6K 24h volume), while Champion Pacific Indonesia Tbk. trades at Rp414 (market cap 384.1B, 16.2K 24h volume). The key difference: Bank Maspion Indonesia Tbk. is far larger — about 22.1× Champion Pacific Indonesia Tbk.'s market cap, and Champion Pacific Indonesia Tbk. is more actively traded (16.2K versus 6.6K). Which is the better fit depends on your goals.
| BMAS | IGAR | |
|---|---|---|
Market Cap | 8.49T | 384.1B |
Volume | 6.6K | 16.2K |
Lot | 66 | 162 |
Turnover | 3.12M | 6.65M |
Average Price | 472.15 | 410.64 |
Value | 3.12M | 6.65M |
Indicative Equilibrium Price | — | 414 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Maspion Indonesia Tbk (the Bank) was established on November 6, 1989 based on Notarial Deed No. 68 of Soetjipto, S.H., which was amended by Notarial Deed No. 49 dated December 5, 1989 of the same notary. The Bank started its commercial operations in 1990. As of December 31, 2012, the Bank has 10 domestic branches, 27 sub-branches, 10 cash offices and 45 Automatic Teller Machines (ATMs) located at Surabaya, Jakarta, Semarang, Denpasar, Medan, Bandung, Makassar, Malang, Solo and Purwokerto.
Read more on BMAS →PT Champion Pacific Indonesia Tbk (The Company) formerly PT Kageo Igar Jaya was established under the name of PT Igar Jaya based on Notarial deed No. 195 dated October 30, 1975, of Mohamad Said Tadjoedin, SH, Notary in Jakarta. Igar Jaya was founded in October 1975 in the Republic of Indonesia as a joint venture with Owens-Illinois, a leading glass container manufacturer in the United States, initially in the production of glass vial and ampoules to support Indonesia’s pharmaceutical industry. However since 1987, due to customer demand, the Company has expanded to the business of plastic, aluminum foil (flexible packaging) and paper folding carton packaging products as well as disposable syringe not only to meet the needs of Indonesia’s pharmaceutical industry but also its cosmetic and food industries. In 1988, the Company relinquished its joint venture status with a view to entering the global market and today has customers in 14 countries outside Indonesia. These include: Britain, Bangladesh, Canada, Guinea, Malaysia, Mauritius, Pakistan, the Philippines, Saudi Arabia, Singapore, Thailand, Trinidad & Tobago, the United States and Zaire.
Read more on IGAR →